The study introduces a novel quadruple pegRNA strategy (QuadPE) for efficient, site-specific insertion of large DNA fragments, achieving up to 40% integration efficiency for payloads ranging from 1.6 to 26 kb, significantly outperforming existing methods for larger insertions while minimizing off-target effects. QuadPE is effective in both dividing and non-dividing cells, making it a promising tool for gene therapy applications.
The QuadPE strategy represents a significant breakthrough in gene editing by enabling efficient and precise insertion of large DNA fragments up to 26 kb without double-stranded breaks or recombinases, achieving around 40% efficiency across multiple loci with minimal off-target effects. This advancement could greatly enhance the capabilities of genetic therapies for complex disorders, especially since it is effective in both dividing and non-dividing primary cells, including human T cells and neurons. Researchers and developers in gene editing should consider integrating QuadPE into their methodologies to improve the accuracy and efficiency of large-fragment insertions.